Timo Rückert

Title: Timo Rückert: Innovator in Immunotherapy

Introduction

Timo Rückert is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of immunotherapy, particularly in the activation and expansion of natural killer (NK) cells. His innovative work has the potential to impact the treatment of various medical conditions associated with pathogenic cells.

Latest Patents

Timo Rückert holds a patent for the invention titled "Activation and expansion of NKG2C+ NK cells." This invention relates to an isolated peptide that serves as a medicament. The peptide consists of 9 to 30 amino acids and includes an amino acid sequence according to SEQ ID NO 1 (VMAPRTLXL). The invention emphasizes the use of this peptide to expand and activate NKG2C+ natural killer cells, which are crucial in the immune response against pathogenic cells expressing HLA-E.

Career Highlights

Rückert is affiliated with the Deutsches Rheuma-forschungszentrum Berlin, where he conducts research and develops innovative therapeutic strategies. His work focuses on enhancing the immune system's ability to combat diseases, showcasing his commitment to advancing medical science.

Collaborations

Timo Rückert collaborates with notable colleagues, including Chiara Romagnani and Quirin Hammer. These partnerships enhance the research efforts and contribute to the development of effective treatments in immunotherapy.

Conclusion

Timo Rückert's contributions to the field of immunotherapy through his innovative patent demonstrate his dedication to improving medical treatments. His work in activating and expanding NK cells holds promise for future advancements in combating diseases.